Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Sept 2025 for Jasper Therapeutics, Inc., €84k. Read the official filing
Filing timeline
BuySaleJudith Anne Shizuru
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -73.9%Entry 2.33 · Close at T+365 0.61
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Judith Anne Shizuru: trading record in brief
Judith Anne Shizuru discloses dealings in Jasper Therapeutics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 12 October 2022 to 22 September 2025.
On the market, this insider has only ever bought: 1 purchase, €84k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. So far in 2025, the count stands at 1 purchase and no sales.
The newest entry dates from 24 September 2025: an open-market purchase of €84k, in Jasper Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Judith Anne Shizuru
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
41,000 shares@ US$2.43100.0% of flowVoting Common StockSEC:0001213900-25-091096:0
Canonical exit: 21 Dec 2025 (T+90)
29,500 shares0Voting Common StockSEC:0001213900-22-063943:0
2 of 2 declarations
